`______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________________
`
`MYLAN PHARMACEUTICALS INC.,
`Petitioner
`
`v.
`NOVO NORDISK A/S,
`Patent Owner
`______________________
`Case IPR2023-00724
`Patent 10,335,462
`______________________
`
`PATENT OWNER’S SUPPLEMENTAL MANDATORY NOTICE
`INFORMATION UNDER 37 C.F.R. § 42.8
`
`
`
`
`
`
`
`
`
`IPR2023-00724
`U.S. Patent 10,335,462
`
`Pursuant to 37 C.F.R. § 42.8, the undersigned, on behalf of and acting in a
`
`representative capacity for Patent Owner, Novo Nordisk A/S, hereby submits this
`
`Supplemental Mandatory Notice, which updates the lead and backup counsel of
`
`record information.
`
`Lead and Back-Up Counsel and Service Information Under §§42.8(b)(3)-
`
`(4): Lead: J. Steven Baughman (Reg. No. 47,414), GROOMBRIDGE, WU,
`
`BAUGHMAN & STONE LLP, 801 17th Street, NW, Suite 1050, Washington, DC,
`
`20006, P: (202)-505-5832, steve.baughman@groombridgewu.com. Backup: Megan
`
`Raymond (Reg. No. 72,997), GROOMBRIDGE, WU, BAUGHMAN & STONE
`
`LLP, 801 17th Street, NW, Suite 1050, Washington, DC, 20006, P: (202)-505-5878,
`
`megan.raymond@groombridgewu.com, and Michael F. Milea (Reg. No. 71,863),
`
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP, 565 5th Avenue, Suite
`
`2900, New York, NY 10017, P: 332-269-0029, mike.milea@groombridgewu.com.
`
`Electronic service of documents must be sent to each of the listed email addresses of
`
`the counsel and Novo-Semaglutide-IPR@groombridgewu.com. To the extent
`
`physical documents are served on Novo Nordisk A/S, please address any such
`
`correspondence to lead counsel and back-up counsel at the following mailing
`
`addresses : J. Steven Baughman, Megan Raymond, GROOMBRIDGE, WU,
`
`BAUGHMAN & STONE LLP, 801 17th Street, NW, Suite 1050, Washington, DC,
`
`20006 and Michael F. Milea, GROOMBRIDGE, WU, BAUGHMAN & STONE
`2
`
`
`
`
`
`
`LLP, 565 5th Avenue, Suite 2900, New York, NY 10017.
`
`IPR2023-00724
`U.S. Patent 10,335,462
`
`Dated: December 28, 2023
`
`
`
`Respectfully submitted,
`
`By: /Megan Raymond /
`
`J. Steven Baughman (Reg. No. 47,414)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`801 17th Street, NW, Suite 1050
`Washington, DC, 20006
`P: (202)-505-5832
`steve.baughman@groombridgewu.com
`
`Megan Raymond (Reg. No. 72,997)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`801 17th Street, NW, Suite 1050
`Washington, DC, 20006
`P: (202)-505-5878
`megan.raymond@groombridgewu.com
`
`Michael F. Milea (Reg. No. 71,863)
`GROOMBRIDGE, WU, BAUGHMAN & STONE LLP
`565 5th Avenue, Suite 2900
`New York, NY 10017
`P: 332-269-0029
`mike.milea@groombridgewu.com
`
`Attorneys for Patent Owner Novo Nordisk A/S
`
`
`
`3
`
`
`
`
`
`
`
`
`
`
`
`
`
`IPR2023-00724
`U.S. Patent 10,335,462
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of PATENT OWNER’S
`
`SUPPLEMENTAL MANDATORY NOTICE INFORMATION UNDER 37 C.F.R.
`
`§ 42.8 has been served in its entirety by causing the aforementioned document to be
`
`electronically mailed to the following attorneys of record for Petitioner listed below:
`
`Petitioner’s Counsel of Record:
`
`Lead Counsel:
`
`Brandon M. White
`Reg. No. 52,354
`White-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`By Electronic Mail
`Backup Counsel: Emily J. Greb
`Reg. No. 68,244
`Greb-ptab@perkinscoie.com
`Perkins Coie LLP
`33 East Main Street
`Madison, WI 53703
`Telephone: (608) 663-7460
`
`Courtney Prochnow, PhD
`Reg. No. 67,639
`Prochnow-ptab@perkinscoie.com
`Perkins Coie LLP
`633 W. 5th St., Ste 5850
`Los Angeles, CA 90071
`Telephone: (310) 788-9900
`
`Christopher D. Jones
`Reg. No. 76,472
`4
`
`
`
`
`
`
`
`
`
`
`
`IPR2023-00724
`U.S. Patent 10,335,462
`
`Jones-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`Jonathan I. Tietz, PhD
`Reg. No. 76,753
`Tietz-ptab@perkinscoie.com
`Perkins Coie LLP
`700 13th Street, NW
`Washington, DC 20005
`Telephone: (202) 654-6200
`
`Matthew A. Lembo
`Reg. No. 75,633
`Lembo-ptab@perkinscoie.com
`Perkins Coie LLP
`1155 Avenue of the Americas
`Floor 22
`New York, NY 10036
`Telephone: (212) 262-6900
`
`Semaglutide-Ozempic@perkinscoie.com
`By Electronic Mail
`
`Dated: December 28, 2023
`
`
`
`Respectfully submitted,
`By: /Sayem Osman/
`Sayem Osman
`
`5
`
`